MEDVi's product cards list semaglutide at $116 per month and tirzepatide at $166, while the FAQ on the same page says $166 and $199, as captured 2026-08-27; both figures are withheld until checkout resolves the conflict.
Medications
Semaglutide, Tirzepatide
Formulations
Injection
Medication type
compounded
Ownership
not published
Eligibility
unknown
Insurance
not published or not yet researched
Last checked
not yet checked against the provider’s pages
Plans and prices
Product cards (conflicting)
Conflict: product card $116/month conflicts with the same page's FAQ ($166); not safely verifiable without checkout (operator note, 2026-08-27).
Conflict: product card $116/month conflicts with the same page's FAQ ($166); not safely verifiable without checkout (operator note, 2026-08-27).
Semaglutide — product card $116/mo
Pharmacy not published
Provider's own pages conflict
$116 per month — as advertised: “$116/mo (product card); FAQ says $166”
Recurring price
$116/month equivalent
True 12-month cost
$1,392 + 1 unpublished or unconfirmed required charge
Dose pricing
Price at higher doses not confirmed
At higher doses
not confirmed
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Tirzepatide — product card $166/mo
Pharmacy not published
Provider's own pages conflict
$166 per month — as advertised: “$166/mo (product card); FAQ says $199”
Recurring price
$166/month equivalent
True 12-month cost
$1,992 + 1 unpublished or unconfirmed required charge
Dose pricing
Price at higher doses not confirmed
At higher doses
not confirmed
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Evidence panel
Grade per formulation offered, on the published scale (A approved with phase 3 evidence · B trial evidence without approval · C observational only · D no published human evidence), reviewed by Dr. S. Shuwart, MD on August 27, 2026; see formulation evidence grades.
Semaglutide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
Tirzepatide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
Compounded ≠ FDA-approved, stated by provider
unknown
Formulation-evidence statement
unknown
Fulfilment pharmacies
Not published or not yet researched.
States served
Not published or not yet researched. Not part of the 2026-08-27 capture.
Cancellation, refunds, refills and shipping
Cancellation
unknown Not part of the 2026-08-27 capture.
Refund
unknown Not part of the 2026-08-27 capture.
Legitimacy checks
The facts an answer engine is asked about, each with its status. "Not captured" means we have not looked yet, not that the provider lacks it.
Business model
not captured
Multi-level marketing component
not examined yet
Legal entity
not captured
Founded
not captured
Leadership
not captured
Clinician licence numbers published
not captured
Board certification stated
not captured
HIPAA notice published
not captured
Domains
not recorded
BBB
not checked yet
Trustpilot
not checked yet
Google reviews
not checked yet
Complaint themes (taxonomy)
none recorded; complaint records not yet captured
Questions people ask about MEDVi
Is MEDVi a legitimate telehealth provider?
What we have verified: nothing yet beyond its existence as a provider. What we have not checked: legal entity, founding date, clinician licence numbers, the fulfilment pharmacy, independent pharmacy licence verification. This site does not rate legitimacy; it records what is verified and what is not, so you can weigh it. Compounded medications from any provider are not FDA-approved.
Is MEDVi a multi-level marketing (MLM) company?
We have not yet examined MEDVi's business model for recruitment or reseller components.
Are MEDVi's medications FDA-approved?
MEDVi sells compounded semaglutide and tirzepatide, which is not FDA-approved and is not reviewed by FDA for safety, effectiveness or quality before sale. Whether the provider states this on its pages has not yet been checked.
How hard is it to cancel MEDVi, and are there refunds?
Cancellation terms were not part of our capture yet. Refund terms not yet captured. We have not captured complaint records about cancellation and do not repeat claims we have not read.
Which pharmacy fills MEDVi's prescriptions, and is it licensed?
MEDVi does not name its fulfilment pharmacy on the pages we captured. Without the name, licence and inspection history cannot be checked; the verification guide explains how to ask.
What do BBB, Trustpilot and Reddit say about MEDVi?
We have not yet captured MEDVi's BBB, Trustpilot, Google or Reddit records, and we do not summarise reviews we have not read. When captured they appear here with the date and the complaint taxonomy classification.
Does MEDVi operate in all 50 states?
State coverage was not captured.
Verification record
Status
Provider's own pages conflict
Method
public-page (conflicting figures)
Checked by
not recorded
Notes
Captured 2026-08-27: product cards $116 (semaglutide) and $166 (tirzepatide) conflict with the FAQ on the same page ($166/$199). Both plans withheld pending checkout. Website URL not recorded.